CFLAR and neoplasm: It directly eliminates tumour-activated endothelium (TAE) by using the Fas/FasL intrinsic death pathway and inhibiting the production of cellular-FLICE-like inhibitory protein (c-FLIP), which is a variant of the pro-apoptotic caspase-8 protein [51].